发明授权
US08309530B2 Compositions and methods for modulating ghrelin-mediated conditions
有权
用于调节生长素释放肽介导的病症的组合物和方法
- 专利标题: Compositions and methods for modulating ghrelin-mediated conditions
- 专利标题(中): 用于调节生长素释放肽介导的病症的组合物和方法
-
申请号: US12700009申请日: 2010-02-04
-
公开(公告)号: US08309530B2公开(公告)日: 2012-11-13
- 发明人: Eva Szentirmai , Levente Kapas , James M. Krueger
- 申请人: Eva Szentirmai , Levente Kapas , James M. Krueger
- 申请人地址: US WA Pullman
- 专利权人: Washington State University
- 当前专利权人: Washington State University
- 当前专利权人地址: US WA Pullman
- 代理机构: Davis Wright Tremaine LLP
- 代理商 Barry L. Davison
- 主分类号: C12N15/11
- IPC分类号: C12N15/11
摘要:
In certain aspects, the preproghrelin gene, but not the ghrelin receptor (GHS-R1a) is required for normal integration of thermoregulation and sleep in mice. Particular aspects provide methods for modulation of thermoregulation and other ghrelin-mediated conditions (e.g., reduction of appetite or food intake, reduction of body weight or treatment of obesity, reduction of body temperature or induction of hypothermia, etc.), comprising administration of an inhibitor of ghrelin expression, and including, e.g., siRNA inhibition for treatment of obesity and for modulation of thermoregulation (e.g., induction of hypothermia in surgical settings benefiting from same). Additionally provided are methods for reducing body temperature or induction of hypothermia, comprising administration to a mammalian subject in need thereof an amount of an anti-obestatin antibody agent sufficient to reduce body temperature or induce hypothermia. Further methods comprise administration of a ghrelin peptide antagonist.
公开/授权文献
信息查询
IPC分类: